Florian Rieder, MD
Inflammatory Bowel Disease GastroenterologyGastroenterology
Highlights
Age Groups Seen
- Adult
Languages
- German
- English
Gender
MaleAbout Florian Rieder
Biography
Dr. Rieder is Staff in the Department of Gastroenterology, Hepatology and Nutrition as well as an Investigator in the Department of Inflammation & Immunity at the Cleveland Clinic, Cleveland, OH.
Dr. Rieder’s clinical focus is Inflammatory Bowel Diseases (Crohn’s disease and Ulcerative colitis) and his area of interest has been appreciated through leadership roles or participation in several clinical guidelines.
Dr. Rieder is internationally recognized for his work on intestinal strictures. He has published more than 200 articles and book chapters and serves on multiple committees, speakers’ panels, editorial boards and steering committees. Dr. Rieder received multiple awards, including the Fellowship Award of the Crohn’s and Colitis Foundation of America, the best abstract award of the American Gastroenterology Association and the Crohn’s and Colitis Foundation, the best poster award of the United European Gastroenterology Federation, three consecutive Excellence in Teaching Awards for exceptional teaching achievements at the Cleveland Clinic, multiple NIH awards (T32, P30 Pilot, K08, R01). He is leading /co-leading two global research consortia. Dr. Rieder won the Sherman Emerging Leadership Award.
Education & Board Certifications
Education
- Fellowship: Cleveland Clinic, 2016
- Residency: Cleveland Clinic, 2012
- Fellowship: Cleveland Clinic, 2010
- Fellowship: Cleveland Clinic, 2009
- Fellowship: Harvard Medical School, 2007
- Medical Education: Ludwig-Maximilians-Universitat, 2004
- Graduate School: Ludwig-Maximilians-Universitat, 2004
Board Certifications
- Gastroenterology: American Board of Internal Medicine, 2016
Professional Highlights
- Chair, Section chair and panel member in Clinical consensus guidelines on Fibrostenosing Crohn’s disease, Ulcerative colitis and Crohn’s disease of the European Crohn’s and Colitis Organization
- Associate Editor, Clinical and Translational Gastroenterology
- Associate Editor, BMC Gastroenterology
- Chair, Y-ECCO
- Excellence in Teaching awards, Cleveland Clinic
- Research Awards, German Research Foundation and European Crohn’s and Colitis Organization
- Fellowship Award, Crohn’s and Colitis Foundation of America
- NIH-T32, P30 Pilot and K08 awards
- Scientific Committee, European Crohn’s and Colitis Organization
- Professional Education Committee, Crohn’s and Colitis Foundation of America
Innovations & Patents
Research & Publications
See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.
As of 2026-01-13, Dr. Rieder has reported the financial relationships with the companies listed below.
Consulting and/or Speaking. Dr. Rieder receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:
- Merck & Co., Inc.
- Sanofi Genzyme
- AbbVie, Inc.
- Lilly USA, LLC
- Palisade Bio, Inc.
- Boehringer Ingelheim
- Agomab Therapeutics
- Redx Pharma, Plc
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.